2022
DOI: 10.1002/ctm2.988
|View full text |Cite
|
Sign up to set email alerts
|

IL‐34 deficiency impairs FOXP3+ Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis

Abstract: The impact of an IL-34 deficiency at steady state, upon challenges and its use as a therapeutic tool.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 10 publications
(17 citation statements)
references
References 53 publications
2
14
0
Order By: Relevance
“…In addition, IL‐34 promotes transplant tolerance 5 . This justifies the current work of Freuchet et al 3 . that studies three different aspects of IL‐34, that is its role in autoimmune responses, its therapeutic potential and its role as a new biomarker to predict kidney graft survival (Figure 1).…”
Section: Figuresupporting
confidence: 55%
See 4 more Smart Citations
“…In addition, IL‐34 promotes transplant tolerance 5 . This justifies the current work of Freuchet et al 3 . that studies three different aspects of IL‐34, that is its role in autoimmune responses, its therapeutic potential and its role as a new biomarker to predict kidney graft survival (Figure 1).…”
Section: Figuresupporting
confidence: 55%
“…The second observation is that IL‐34 is another drug candidate to prevent graft or host rejection, as demonstrated in xenogeneic skin graft transplantation or graft‐versus‐host disease (GvHD) (Figure 1). However, IL‐34 should be associated with suboptimal doses of rapamycin 3 . This supports again the importance of Treg, as rapamycin has been shown to spare and potentiate Treg in contrast to calcineurin inhibitors 10 .…”
Section: Figurementioning
confidence: 66%
See 3 more Smart Citations